Literature DB >> 29861371

Procalcitonin as a diagnostic marker for sepsis/septic shock in the emergency department; a study based on Sepsis-3 definition.

Sun Ju Kim1, Sumg Oh Hwang1, Yong Won Kim2, Jun Hyeok Lee3, Kyoung-Chul Cha4.   

Abstract

INTRODUCTION: The recent definition of sepsis was modified based on a scoring system focused on organ failure (Sepsis-3). It would be a time-consuming process to detect the sepsis patient using Sepsis-3. Procalcitonin (PCT) is a well-known biomarker for diagnosing sepsis/septic shock and monitoring the efficacy of treatment. We conducted a study to verify the predictability of PCT for diagnosing sepsis based on Sepsis-3 definition. MATERIALS &
METHODS: This is a retrospective cohort study. The patients whose PCT was measured on the emergency department (ED) arrival and had final diagnosis related infection were enrolled. The patients were categorized by infection, sepsis, or septic shock followed by Sepsis-3 definition. "Pre-septic shock" was defined when a patient was initially diagnosed with sepsis, following which his/her mean arterial blood pressure decreased to under 65 mmHg refractory to fluid resuscitation and there was need for vasopressor use during ED admission. Receiver operating characteristics (ROC) curve and area under the curve (AUC) analysis were performed to verify sensitivity and specificity of PCT.
RESULTS: 866 patients were enrolled in the final analysis. There are 287 cases of infection, 470 cases of sepsis, and 109 cases of septic shock. An optimal cutoff value for diagnosing sepsis was 0.41 ng/dL (sensitivity: 74.8% and specificity: 63.8%; AUC: 0745), septic shock was 4.7 ng/dL (sensitivity: 66.1% and specificity: 79.0%; AUC: 0.784), and "pre-septic shock" was 2.48 ng/dL (sensitivity: 72.8%, specificity: 72.8%, AUC: 0.781), respectively.
CONCLUSION: PCT is a reliable biomarker to predict sepsis or septic shock according to the Sepsis-3 definitions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Emergency department; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 29861371     DOI: 10.1016/j.ajem.2018.05.047

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  3 in total

1.  Marked Elevation in Serum Procalcitonin Levels Do Not Correlate With Severity of Disease or Mortality in Hospitalized Patients: A Retrospective Study.

Authors:  Richard J Durrance; Tofura Ullah; Harsh Patel; Grace Martinez; Kelly Cervellione; Veronica B Zafonte; Khalid Gafoor; Farshad Bagheri
Journal:  Biomark Insights       Date:  2020-05-15

Review 2.  Biomarkers for Point-of-Care Diagnosis of Sepsis.

Authors:  Andrew Teggert; Harish Datta; Zulfiqur Ali
Journal:  Micromachines (Basel)       Date:  2020-03-10       Impact factor: 2.891

3.  Assessment of a Cellular Host Response Test as a Sepsis Diagnostic for Those With Suspected Infection in the Emergency Department.

Authors:  Hollis R O'Neal; Roya Sheybani; Terrell S Caffery; Mandi W Musso; Diana Hamer; Shannon M Alwood; Matthew S Berlinger; Tonya Jagneaux; Katherine W LaVie; Catherine S O'Neal; Michael A Sanchez; Morgan K Walker; Ajay M Shah; Henry T K Tse; Christopher B Thomas
Journal:  Crit Care Explor       Date:  2021-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.